ChrysCapital, through its investment vehicle Dali Limited sold 485733 lac shares of Hexaware Technologies through an open market transaction for a total consideration of R61.42 Cr. The PE firm offloaded 1.628% stake in the IT firm by selling 3010047 lac shares at R126.48 each on NSE and 1,845,736 lac shares at R126.51 each on BSE.
ChrysCapital held 2.86 Cr shares, equivalent to 9.59 % stake in Hexaware Technologies as on June 2013.
Hexaware Technology has been in the lamplight for making one of the largest PE deals in India's $108 billion IT exports sector – Baring PE Asia’s buyout deal in Hexaware for R2,745 Cr.
Baring would buy the stakes of Nishar family and General Atlantic and then initiate a tender offer for another 26% stake of Hexaware for R1,058 Cr which is expected to open on October 18 and close on October 31, 2013.
Hexaware is India's ninth largest IT exporter with annualized revenue of R912 Cr in calendar 2012.
Hexaware on BSE
ChrysCapital is an India focused investment firm managing $2.5 billion across six funds. Its current investments include; Amtek Group , Eris Lifesciences , Gammon, HCL Technologies, ING Vysya Bank, Intas Pharma, JMT Auto, KPIT Cummins, Mankind Pharma, NCC, Parksons, Pratibha Industries, Simplex Infra, Spanco Tele.
Deals executed by ChrysCap this year, offloaded 9 lac shares for R105 per piece of Ahmednagar Forgings; invested R250 Cr in CavinKare; acquired 10% stake in NBFC - Au Financiers for R120 Cr.
Other deals in this space;
Rakesh Jhunjhunwala had bought 25 Mn shares of Firstsource Solutions on NSE through a bulk deal transaction amounting to R25 Cr from ICICI and others.
Emerging Markets Sudan Free Equity Index Fund had offloaded 86.24 lakh shares of Satyam Computer Services amounting to R98.47 Cr.
Zensar Technologies, an outsourcing service firm, was planning to acquire two companies in the US to strengthen its presence in the largest export market.
British Telecom had sold its remaining 9.1% stake in Tech Mahindra for around $183 Mn by offloading more than 11.6 Mn shares through block deals.
Deutsche Securities Mauritius Limited has sold its 1.95 percent stake in Jubilant Life Sciences Limited, a global life sciences and pharmaceutical company, for just over INR122 crore. The sale of the stake was performed as an open market transaction, and purchased by Citigroup Global Markets Mauritius Pvt. Ltd.